BLLN
BillionToOne, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-11
Figures on this page computed 2026-11-08 12:40 UTC
Last close
113.94USD
Market data, 2026-11-06
Except where said otherwise: 10-K for 2025, filed 2026-03-11
633.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-11
16.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
2.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
5.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
0.23Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.04 against 0.36 on the market's range.
- Growth117.9%88 of 100, above its sector
- Returns on capital16.6%61 of 100, above its sector
- Margins68.3%61 of 100, above its sector
- Price633.0x5 of 100, below its sector
- Safety0.2389 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Measure by measure
behind on 0 of 4- Profit on each unit of sales2.4%-0.9%Ahead
Higher is better here.
- Return on the capital it uses16.6%-0.7%Ahead
Higher is better here.
- Sales growth over five yearsn/a13.2%n/a
Higher is better here.
- Debt against equity0.230.39Ahead
Lower is better here.
- Gross margin68.3%46.9%Ahead
Higher is better here.
- Price against earnings633xn/an/a
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Neogen Corporation, BLLN is behind on 0 of 4 measures.
Against Neogen Corporation, BLLN is behind on 0 of 4 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-03-11
Profit on each unit of sales2.4%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
Return on the capital it uses16.6%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
Sales growth over five yearsn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
Debt against equity0.23
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
Gross margin68.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD
Price against earnings633.0x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0002070849-26-000017
- Reported in
- USD